Fly News Breaks for November 14, 2019
Nov 14, 2019 | 08:02 EDT
Jefferies analyst Brandon Couillard believes Thermo Fisher's (TMO) balance sheet has "more than enough capacity" to support an $11B-plus acquisition and he thinks Qiagen (QGEN) "would fit reasonably well." Bloomberg last night reported that the two companies a near a possible deal. Further, antitrust implications, while less clear right now, are unlikely big enough to derail a deal, adds the analyst. His initial view "conservatively suggests" 5%-6% accretion to Thermo Fisher. Couillard thinks Qiagen could be worth $40 to $45 per share in a buyout based on historical deal comps.
News For TMO;QGEN From the Last 2 Days
There are no results for your query TMO;QGEN